239 related articles for article (PubMed ID: 26636727)
1. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR
Orbit; 2016; 35(1):29-34. PubMed ID: 26636727
[TBL] [Abstract][Full Text] [Related]
2. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
Finger PT; Sedeek RW; Chin KJ
Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
[TBL] [Abstract][Full Text] [Related]
3. Interferon alpha for the treatment of melanocytic conjunctival lesions.
Herold TR; Hintschich C
Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):111-5. PubMed ID: 19756691
[TBL] [Abstract][Full Text] [Related]
4. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
5. Primary acquired melanosis of the conjunctiva: risks for progression to melanoma in 311 eyes. The 2006 Lorenz E. Zimmerman lecture.
Shields JA; Shields CL; Mashayekhi A; Marr BP; Benavides R; Thangappan A; Phan L; Eagle RC
Ophthalmology; 2008 Mar; 115(3):511-519.e2. PubMed ID: 17884168
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection.
Kikuchi I; Kase S; Ishijima K; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2271-2276. PubMed ID: 28752368
[TBL] [Abstract][Full Text] [Related]
7. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P; Huerva V
Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
[TBL] [Abstract][Full Text] [Related]
8. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
9. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy].
Kase S; Ishijima K; Noda M; Ishida S
Nippon Ganka Gakkai Zasshi; 2011 Nov; 115(11):1043-7. PubMed ID: 22171510
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
[TBL] [Abstract][Full Text] [Related]
12. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
Boehm MD; Huang AJ
Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
[TBL] [Abstract][Full Text] [Related]
13. Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia.
Huerva V; Traveset AE; Vilardell F
Ocul Immunol Inflamm; 2017 Apr; 25(2):284-286. PubMed ID: 26765558
[No Abstract] [Full Text] [Related]
14. [Conjunctival primary acquired melanosis].
Krohn J; Monge OR
Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
[TBL] [Abstract][Full Text] [Related]
15. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
Pe'er J; Frucht-Pery J
Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
[TBL] [Abstract][Full Text] [Related]
16. Primary acquired melanosis with atypia treated with mitomycin C.
Anandajeya WV; Corrêa ZM; Augsburger JJ
Int Ophthalmol; 2009 Aug; 29(4):285-8. PubMed ID: 18438612
[TBL] [Abstract][Full Text] [Related]
17. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
Chalasani R; Giblin M; Conway RM
Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
[TBL] [Abstract][Full Text] [Related]
18. Resolution of conjunctival melanoma with topical interferon alpha 2b in a patient with mitomycin C intolerance.
Chaparro Tapias TA; Díaz Díaz AL; Secondi R; Coy Villamil H; Sánchez España JC
Arch Soc Esp Oftalmol (Engl Ed); 2018 Nov; 93(11):558-561. PubMed ID: 30072188
[TBL] [Abstract][Full Text] [Related]
19. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
Krilis M; Tsang H; Coroneo M
Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
[TBL] [Abstract][Full Text] [Related]
20. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
